Corient Private Wealth LP Sells 19,693 Shares of Corteva, Inc. $CTVA

Key Points

• Corient Private Wealth reduced its Corteva stake by 9.6% in the second quarter, selling 19,693 shares and retaining 185,375 shares valued at approximately $15.7 million. Institutional investors collectively own 81.54% of Corteva.
• Wall Street maintains a generally positive outlook, with 14 analysts rating Corteva a Buy and nine assigning a Hold rating. The stock has a consensus price target of $91.50 versus its recent price of $83.43.
• Corteva exceeded quarterly earnings expectations with adjusted EPS of $2.30, though revenue declined 1.2% year over year to $6.38 billion. The company also pays a quarterly dividend of $0.18 per share, yielding about 0.9% annually.

Corient Private Wealth LP lessened its stake in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 9.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 185,375 shares of the company's stock after selling 19,693 shares during the period. Corient Private Wealth LP's holdings in Corteva were worth $15,700,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. EFG International AG bought a new stake in shares of Corteva during the 2nd quarter worth $25,000. Compass Financial Management LLC bought a new position in Corteva in the 2nd quarter worth $25,000. Elevation Wealth Partners LLC lifted its position in Corteva by 334.6% during the 2nd quarter. Elevation Wealth Partners LLC now owns 339 shares of the company's stock worth $29,000 after acquiring an additional 261 shares during the last quarter. Clearstead Trust LLC bought a new stake in Corteva during the second quarter valued at about $31,000. Finally, N.E.W. Advisory Services LLC bought a new stake in Corteva during the second quarter valued at about $33,000. Institutional investors own 81.54% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on CTVA shares. Barclays boosted their price objective on Corteva from $84.00 to $91.00 and gave the stock an "overweight" rating in a research report on Thursday, June 11th. Oppenheimer lifted their price target on Corteva from $89.00 to $95.00 and gave the stock an "outperform" rating in a research report on Thursday, July 23rd. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and set a $101.00 price target on shares of Corteva in a report on Monday, August 3rd. KeyCorp began coverage on shares of Corteva in a research note on Thursday, September 10th. They issued a "sector weight" rating on the stock. Finally, BMO Capital Markets boosted their target price on shares of Corteva from $95.00 to $100.00 and gave the stock an "outperform" rating in a research report on Monday, August 3rd. Fourteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat.com, Corteva has an average rating of "Moderate Buy" and a consensus price target of $91.50.

Corteva Trading Up 1.1%

Shares of Corteva stock opened at $83.43 on Wednesday. The firm has a market capitalization of $55.66 billion, a PE ratio of 55.25, a price-to-earnings-growth ratio of 2.53 and a beta of 0.57. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. The company's fifty day moving average price is $83.35 and its two-hundred day moving average price is $81.44. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $90.97.

Corteva (NYSE:CTVA - Get Free Report) last posted its earnings results on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, beating analysts' consensus estimates of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The business had revenue of $6.38 billion for the quarter, compared to analysts' expectations of $6.60 billion. During the same quarter in the previous year, the firm posted $2.20 earnings per share. The firm's revenue for the quarter was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, analysts expect that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st were issued a dividend of $0.18 per share. The ex-dividend date of this dividend was Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva's dividend payout ratio (DPR) is presently 47.68%.

Trending Headlines about Corteva

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Board formally approved the Vylor distribution. Corteva’s board authorized the previously announced spin-off of its seed operating segment, removing a key procedural hurdle and allowing the separation process to advance toward the scheduled October 1 date. Corteva Board of Directors Approves Vylor Distribution
• Positive Sentiment: Vylor outlined substantial long-term seed growth opportunities. New soybean technology platforms are expected to generate approximately $500 million of incremental revenue by 2035, while the company’s hybrid-wheat platform, Xpedite, is scheduled to launch in late 2027. Vylor also forecasts North American wheat revenue of $500 million by 2035 and $1 billion by 2040, strengthening the strategic rationale for separating the businesses. Vylor to Expand Soybean Leadership Vylor Confirms Breakthrough Wheat Technology
• Neutral Sentiment: Corteva defended the separation against state attorneys general. The company called allegations seeking to block the transaction unfounded and said the future crop-protection business would remain well-capitalized and competitive. The response reinforces management’s commitment, but does not eliminate the possibility of regulatory or litigation-related delays. Corteva Categorically Rejects Allegations
• Neutral Sentiment: Corteva was listed as updating its fiscal 2029 earnings guidance, but no specific EPS figure was provided, limiting the immediate earnings signal for investors.
• Negative Sentiment: State attorneys general are attempting to block the corporate split. Continued opposition creates execution, timing and legal uncertainty around the October 1 separation and could weigh on investor sentiment if the dispute escalates. Corteva Rejects Bid by State Attorneys General

About Corteva

Corteva, Inc is a global agricultural science company that develops and supplies seed, crop protection and digital agriculture solutions. Its products are designed to help farmers improve crop productivity, manage pests and weeds, and address changing environmental and agricultural conditions.

The company's seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crop varieties marketed under brands such as Pioneer and Brevant. Corteva also provides herbicides, insecticides, fungicides and biological products, including solutions associated with its Enlist weed-control system and other crop protection technologies.

Corteva serves farmers, agricultural retailers and other customers across North America, Latin America, Europe, Asia and other international markets.

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.